Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Dormond

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|May 15, 2019
mTOR in Human DiseasesOlivier Dormond
Annals of Emergency Medicine|June 9, 2005
Images in emergency medicine. Giant pulmonary bullaEmmanuelle Guyot, Olivier Dormond
International Journal of Molecular Sciences|September 26, 2015
PI3K and AKT: Unfaithful Partners in CancerSeraina Faes, Olivier Dormond
The American Journal of Medicine|November 23, 2013
Thoracic aortic dilation/aneurysm in Fabry diseaseOlivier Dormond, Frédéric Barbey
Thrombosis and Haemostasis|September 30, 2003
Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase AOlivier Dormond, Curzio Rüegg
The Annals of Thoracic Surgery|April 25, 2006
Invited commentaryOlivier Dormond, Joren C Madsen
Cancers|April 3, 2021
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer TreatmentAlexandre El Hage, Olivier Dormond
Frontiers in Cell and Developmental Biology|April 1, 2021
Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and PerspectivesSeraina Faes, Nicolas Demartines, Olivier Dormond
Biochemical Society Transactions|March 25, 2011
ATP-competitive inhibitors of mTOR: new perspectives in the treatment of renal cell carcinomaDidier Roulin, Nicolas Demartines, Olivier Dormond
Biochimica Et Biophysica Acta|February 27, 2004
Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesisCurzio Rüegg, Olivier Dormond, Agnese Mariotti
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|May 15, 2019
mTOR in Human DiseasesOlivier Dormond
Annals of Emergency Medicine|June 9, 2005
Images in emergency medicine. Giant pulmonary bullaEmmanuelle Guyot, Olivier Dormond
International Journal of Molecular Sciences|September 26, 2015
PI3K and AKT: Unfaithful Partners in CancerSeraina Faes, Olivier Dormond
The American Journal of Medicine|November 23, 2013
Thoracic aortic dilation/aneurysm in Fabry diseaseOlivier Dormond, Frédéric Barbey
Thrombosis and Haemostasis|September 30, 2003
Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase AOlivier Dormond, Curzio Rüegg
The Annals of Thoracic Surgery|April 25, 2006
Invited commentaryOlivier Dormond, Joren C Madsen
Cancers|April 3, 2021
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer TreatmentAlexandre El Hage, Olivier Dormond
Frontiers in Cell and Developmental Biology|April 1, 2021
Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and PerspectivesSeraina Faes, Nicolas Demartines, Olivier Dormond
Biochemical Society Transactions|March 25, 2011
ATP-competitive inhibitors of mTOR: new perspectives in the treatment of renal cell carcinomaDidier Roulin, Nicolas Demartines, Olivier Dormond
Biochimica Et Biophysica Acta|February 27, 2004
Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesisCurzio Rüegg, Olivier Dormond, Agnese Mariotti
Pageof 7